Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database

IntroductionWorld Health Organization (WHO) Grade III meningioma is a central nervous system tumor with a poor prognosis. In this retrospective cohort study, the authors constructed a nomogram for predicting the prognosis of WHO Grade III meningioma.MethodsThe patients of this nomogram were based on...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zetian Jia, Yaqi Yan, Jiuxin Wang, He Yang, Haihua Zhan, Qian Chen, Yawei He, Yuhua Hu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/3e8735f867e1413492070bc67a9e091c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3e8735f867e1413492070bc67a9e091c
record_format dspace
spelling oai:doaj.org-article:3e8735f867e1413492070bc67a9e091c2021-12-01T22:05:15ZDevelopment and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database2234-943X10.3389/fonc.2021.719974https://doaj.org/article/3e8735f867e1413492070bc67a9e091c2021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.719974/fullhttps://doaj.org/toc/2234-943XIntroductionWorld Health Organization (WHO) Grade III meningioma is a central nervous system tumor with a poor prognosis. In this retrospective cohort study, the authors constructed a nomogram for predicting the prognosis of WHO Grade III meningioma.MethodsThe patients of this nomogram were based on the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2018. All patients were randomly divided into a development cohort (964 patients) and a validation cohort (410 patients) in a 7:3 ratio. The least absolute shrinkage and selection operator (LASSO) regression was used to screen the predictors. The Cox hazards regression model was constructed and the prognosis was visualized by nomogram. The performance of the prognostic nomogram was determined by consistency index (C-index), clinical net benefit, and calibration.ResultsEight variables were included in the nomogram: gender, race, age at diagnosis, histology, tumor site, tumor size, laterality, and surgical method. The C-index of the training set and verification set were 0.654 and 0.628. The calibration plots showed that the nomogram was in good agreement with the actual observation. The clinical decision curve indicates that the nomogram has a good clinical net benefit in WHO Grade III meningioma.ConclusionsA prognostic nomogram of a large cohort of WHO Grade III meningioma was established and verified based on the SEER database. The nomogram we established may help clinicians provide personalized treatment services and clinical decisions for patients.Zetian JiaYaqi YanJiuxin WangHe YangHaihua ZhanQian ChenYawei HeYuhua HuFrontiers Media S.A.articlemeningiomasurveillance epidemiology and end resultsnomogramprognosisrisk factorNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic meningioma
surveillance epidemiology and end results
nomogram
prognosis
risk factor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle meningioma
surveillance epidemiology and end results
nomogram
prognosis
risk factor
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Zetian Jia
Yaqi Yan
Jiuxin Wang
He Yang
Haihua Zhan
Qian Chen
Yawei He
Yuhua Hu
Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
description IntroductionWorld Health Organization (WHO) Grade III meningioma is a central nervous system tumor with a poor prognosis. In this retrospective cohort study, the authors constructed a nomogram for predicting the prognosis of WHO Grade III meningioma.MethodsThe patients of this nomogram were based on the Surveillance, Epidemiology, and End Results (SEER) database between 2000 and 2018. All patients were randomly divided into a development cohort (964 patients) and a validation cohort (410 patients) in a 7:3 ratio. The least absolute shrinkage and selection operator (LASSO) regression was used to screen the predictors. The Cox hazards regression model was constructed and the prognosis was visualized by nomogram. The performance of the prognostic nomogram was determined by consistency index (C-index), clinical net benefit, and calibration.ResultsEight variables were included in the nomogram: gender, race, age at diagnosis, histology, tumor site, tumor size, laterality, and surgical method. The C-index of the training set and verification set were 0.654 and 0.628. The calibration plots showed that the nomogram was in good agreement with the actual observation. The clinical decision curve indicates that the nomogram has a good clinical net benefit in WHO Grade III meningioma.ConclusionsA prognostic nomogram of a large cohort of WHO Grade III meningioma was established and verified based on the SEER database. The nomogram we established may help clinicians provide personalized treatment services and clinical decisions for patients.
format article
author Zetian Jia
Yaqi Yan
Jiuxin Wang
He Yang
Haihua Zhan
Qian Chen
Yawei He
Yuhua Hu
author_facet Zetian Jia
Yaqi Yan
Jiuxin Wang
He Yang
Haihua Zhan
Qian Chen
Yawei He
Yuhua Hu
author_sort Zetian Jia
title Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
title_short Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
title_full Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
title_fullStr Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
title_full_unstemmed Development and Validation of Prognostic Nomogram in Patients With WHO Grade III Meningioma: A Retrospective Cohort Study Based on SEER Database
title_sort development and validation of prognostic nomogram in patients with who grade iii meningioma: a retrospective cohort study based on seer database
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/3e8735f867e1413492070bc67a9e091c
work_keys_str_mv AT zetianjia developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
AT yaqiyan developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
AT jiuxinwang developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
AT heyang developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
AT haihuazhan developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
AT qianchen developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
AT yaweihe developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
AT yuhuahu developmentandvalidationofprognosticnomograminpatientswithwhogradeiiimeningiomaaretrospectivecohortstudybasedonseerdatabase
_version_ 1718404155384528896